Sol-gel derived terbium-containing mesoporous bioactive glasses nanospheres: In vitro hydroxyapatite formation and drug delivery B Biointerfaces

Terbium (Tb) doped mesoporous bioactive glasses (Tb/MBG) nanospheres were successfully synthesized by a facile sol-gel method using cetyl trimethyl ammonium bromide (CTAB) as the template. Results indicated that Tb/MBG had spherical morphology (100–200nm), higher specific surface area (250–350m²/g) and narrow mesopore size distribution (2–3nm). In order to investigate the effects of Tb on the in vitro bioactivity, prepared Tb/MBG nanospheres were soaking in simulated body fluid (SBF) for 3 days, and results indicated incorporation Tb ions in the MBG nanospheres could improve the hydroxyapatite formation ability. In addition, Tb/MBG nanospheres showed controlled release property of anti-cancer drugs (DOX) and distinct degradation in PBS with different pH values. Their release mechanism can be explained by Fickian diffusion according the Higuchi model, and the delivery of DOX from Tb/MBG nanospheres can be dominated by changing the doping concentration of Tb and the values of pH. In addition, the cytotoxicity of Tb/MBG nanospheres was assessed using a cell counting kit-8 (CCK-8), and results showed that the synthesized Tb/MBG nanospheres at low concentration had no significant cytotoxicity in MC3T3 cells. These all note that this material is a promising candidate for the therapy of bone tissue regeneration.